These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36976659)

  • 1. Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells.
    Derben FC; Ytting H; Hartleben B; Bantel H; Wedemeyer H; Willemoe GL; Jaeckel E; Taubert R
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36976659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
    Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
    J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    Diestelhorst J; Junge N; Schlue J; Falk CS; Manns MP; Baumann U; Jaeckel E; Taubert R
    PLoS One; 2017; 12(7):e0181107. PubMed ID: 28700730
    [TBL] [Abstract][Full Text] [Related]  

  • 4.  Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
    Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
    Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
    Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
    J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients.
    Latorre I; Esteve-Sole A; Redondo D; Giest S; Argilaguet J; Alvarez S; Peligero C; Forstmann I; Crespo M; Pascual J; Meyerhans A
    Transpl Immunol; 2016 Mar; 35():1-6. PubMed ID: 26836476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.
    Mo R; Feng XX; Wu YN; Wang H; He YP; Sun HH; Guo F; Chen Q; Yan W; Li PY; Liu M; Zhang GM; Tian DA; Feng ZH
    Mol Immunol; 2020 Jul; 123():106-115. PubMed ID: 32485469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
    Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
    J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
    Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
    Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
    Chen J; Liu W; Zhu W
    Med Sci Monit; 2019 Aug; 25():6204-6212. PubMed ID: 31422415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenectomy induces biochemical remission and regeneration in experimental murine autoimmune hepatitis.
    Dywicki J; Buitrago-Molina LE; Noyan F; Schlue J; Iordanidis K; Manns MP; Wedemeyer H; Jaeckel E; Hardtke-Wolenski M
    Eur J Med Res; 2022 Dec; 27(1):284. PubMed ID: 36496477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients.
    Crespo E; Fernandez L; Lúcia M; Melilli E; Lauzurica R; Penin RM; Quer A; Luque S; Quero M; Manonelles A; Torras J; Cruzado JM; Cañas L; Grinyó JM; Bestard O
    Transplantation; 2017 Sep; 101(9):2102-2110. PubMed ID: 28403126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic targets in autoimmune hepatitis.
    Taubert R; Hupa-Breier KL; Jaeckel E; Manns MP
    J Autoimmun; 2018 Dec; 95():34-46. PubMed ID: 30401504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
    Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
    Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    Buitrago-Molina LE; Pietrek J; Noyan F; Schlue J; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E
    J Autoimmun; 2021 Feb; 117():102591. PubMed ID: 33387980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis.
    Roberts SK; Strasser SI; Nicoll AJ; Kemp W; Majeed A; Mitchell J; Stuart K; Gow P; Sood S; MacQuillan G; George J; Mitchell J; McCaughan GW;
    Scand J Gastroenterol; 2020 Nov; 55(11):1309-1317. PubMed ID: 33070650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.
    Kim KW; Chung BH; Kim BM; Cho ML; Yang CW
    Immunology; 2015 Jan; 144(1):68-78. PubMed ID: 24974886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
    An Haack I; Derkow K; Riehn M; Rentinck MN; Kühl AA; Lehnardt S; Schott E
    PLoS One; 2015; 10(11):e0143715. PubMed ID: 26599014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.